Most common nonhematologic adverse events
| WHO preferred term . | Total, n (%) . | Drug-related, n (%) . | Grade 3/4, n (%) . |
|---|---|---|---|
| Fever | 125 (49.6) | 27 (10.7) | 35 (13.0) |
| Nausea | 113 (44.8) | 71 (28.2) | 4 (1.6) |
| Hypokalemia | 111 (44.0) | 28 (11.1) | 61 (24.2) |
| Diarrhea | 101 (40.1) | 40 (15.9) | 12 (4.8) |
| Fatigue | 93 (36.9) | 39 (15.5) | 41 (16.3) |
| Vomiting | 86 (34.1) | 48 (19.0) | 9 (3.6) |
| Anorexia | 76 (30.2) | 31 (12.3) | 18 (7.1) |
| Sepsis/infection | 75 (29.7) | 13 (5.2) | 58 (23.0) |
| Pneumonia | 66 (26.2) | 12 (4.8) | 43 (17.1) |
| Asthenia | 63 (25.0) | 20 (7.9) | 34 (13.5) |
| Skin rash | 48 (19.0) | 27 (10.7) | 11 (4.4) |
| Headache | 43 (17.1) | 12 (4.8) | 7 (2.8) |
| Creatinine increased | 40 (15.9) | 18 (7.1) | 7 (2.8) |
| Edema | 36 (14.3) | 5 (2.0) | 3 (1.2) |
| Skeletal pain | 28 (11.1) | 2 (0.8) | 10 (4.0) |
| Myalgia | 27 (10.7) | 8 (3.2) | 6 (2.4) |
| WHO preferred term . | Total, n (%) . | Drug-related, n (%) . | Grade 3/4, n (%) . |
|---|---|---|---|
| Fever | 125 (49.6) | 27 (10.7) | 35 (13.0) |
| Nausea | 113 (44.8) | 71 (28.2) | 4 (1.6) |
| Hypokalemia | 111 (44.0) | 28 (11.1) | 61 (24.2) |
| Diarrhea | 101 (40.1) | 40 (15.9) | 12 (4.8) |
| Fatigue | 93 (36.9) | 39 (15.5) | 41 (16.3) |
| Vomiting | 86 (34.1) | 48 (19.0) | 9 (3.6) |
| Anorexia | 76 (30.2) | 31 (12.3) | 18 (7.1) |
| Sepsis/infection | 75 (29.7) | 13 (5.2) | 58 (23.0) |
| Pneumonia | 66 (26.2) | 12 (4.8) | 43 (17.1) |
| Asthenia | 63 (25.0) | 20 (7.9) | 34 (13.5) |
| Skin rash | 48 (19.0) | 27 (10.7) | 11 (4.4) |
| Headache | 43 (17.1) | 12 (4.8) | 7 (2.8) |
| Creatinine increased | 40 (15.9) | 18 (7.1) | 7 (2.8) |
| Edema | 36 (14.3) | 5 (2.0) | 3 (1.2) |
| Skeletal pain | 28 (11.1) | 2 (0.8) | 10 (4.0) |
| Myalgia | 27 (10.7) | 8 (3.2) | 6 (2.4) |
WHO indicates World Health Organization.